SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000898432-03-000507
Filing Date
2003-06-09
Accepted
2003-06-09 17:17:18
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13g.txt SC 13G 30476
3 EXHIBIT 99.1 exhibit99-1.txt EX-99.1 2402
  Complete submission text file 0000898432-03-000507.txt   35152
Mailing Address 5110 CAMPUS DRIVE PLYMOUTH MEETING PA 19462
Business Address 5110 CAMPUS DR PLYMOUTH MEETING PA 19462 6109415231
GENAERA CORP (Subject) CIK: 0000880431 (see all company filings)

IRS No.: 133445668 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42170 | Film No.: 03737866
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice